Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMEDGlobeNewsWire · Oct 5, 2026
Standard BioTools Provides Update on Sale of Mass Cytometry BusinessGlobeNewsWire · Sep 30, 2026
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?GuruFocus · Sep 11, 2026
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?PRNewsWire · Sep 11, 2026
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHMGuruFocus · Sep 10, 2026
INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger--IRDM, VRME, VAL and LABGuruFocus · Sep 8, 2026Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.01 | -$0.07 | Miss |
| May 5, 2026 | -$0.02 | -$0.02 | Beat |
| Feb 24, 2026 | -$0.03 | $0.06 | Beat |
| Nov 4, 2025 | -$0.04 | -$0.09 | Miss |
| Aug 11, 2025 | -$0.04 | -$0.04 | Beat |
| May 6, 2025 | -$0.04 | -$0.04 | Beat |